Effect of Consuming Processed Meat Products With Reduced Sodium on Cardiometabolic Risk Biomarkers (InovC4Sa_RCT1)

November 10, 2026 updated by: Mara Sofia Rodrigues, Instituto Politécnico de Bragança

Effects of Consuming Processed Meat Products With Improved Sodium on Profiles on Cardiometabolic Risk Biomarkers

This study aims to evaluate the acute effects of consuming traditional processed meat products with reduced sodium content on blood pressure and urinary sodium excretion in healthy adults.

The study will compare the effects of traditional products with reformulated versions containing 25% and 50% less sodium. The products under evaluation include traditional Portuguese processed meat products such as "alheira", "chouriça" and "butelo".

Participants will consume the different product formulations according to a controlled study protocol.

Blood pressure will be assessed, and urine samples will be collected over a 24-hour period to evaluate sodium excretion.

This study is part of a research project focused on developing healthier traditional meat products while preserving their characteristic sensory properties. The findings may contribute to a better understanding of the effects of sodium reduction in processed meat products on cardiovascular health.

Study Overview

Detailed Description

In Portugal, traditional processed meat products, are valued for their cultural and gastronomic significance. However, their sodium content may be a nutritional concern. Reformulating these products to reduce sodium content represents a potential strategy to improve their nutritional profile while preserving traditional food products.

The InovC4Sa project aims to develop healthier processed meat products through nutritional reformulation, including sodium reduction. The present clinical study focuses on evaluating the acute effects of consuming traditional processed meat products with different levels of sodium reduction.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Mara Rodrigues
  • Phone Number: +351 273 330 950
  • Email: mara@unipb.pt

Study Locations

      • Bragança, Portugal, 5300
        • Recruiting
        • Escola Superior de Saúde - Instituto Politécnico de Bragança
        • Contact:
          • Mara Rodrigues
          • Phone Number: +351 273 330 950
          • Email: mara@unipb.pt
        • Contact:
        • Principal Investigator:
          • Juliana Almeida de Souza, PhD
        • Principal Investigator:
          • Vera Ferro Lebres, PhD
        • Principal Investigator:
          • Mara Rodrigues, MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults aged 18 to 60 years.
  • Male or female participants.
  • Individuals willing to participate and able to provide written informed consent.
  • Users of the Universidade Politécnica de Bragança (UPB) canteen.

Exclusion Criteria:

  • Diagnosis of cardiovascular disease.
  • Diagnosis of metabolic disease.
  • Diagnosis of liver disease.
  • Pregnancy.
  • Breastfeeding. Use of medication that may interfere on blood pressure regulation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Alheira Intervention Group

Participants assigned to this group will consume three different formulations of tradition meat product 1 "alheira" in a day meal: the traditional formulation, a formulation with a 25% reduction in sodium content, and a formulation with a 50% reduction in sodium content. Each participant will receive all three formulations in a randomized sequence, with 7 days washout periods between intervention periods. The other meals of the day and of the previous day are standardized for all participants. The other meals of the day and of the previous day are standardized for all participants.

Participants will consume three formulations of traditional Portuguese alheira: a conventional formulation (traditional sodium content), a reformulated version with a 25% reduction in sodium content, and a reformulated version with a 50% reduction in sodium content. Sodium reduction is achieved through product reformulation, including partial replacement of sodium chloride with potassium chloride. Each formulation will be administered as a separate intervention during the crossover study, with washout periods between intervention periods.

Experimental: Chouriça Intervention Group

Participants assigned to this group will consume three different formulations of a traditional meat product 2 "Chouriça" in a day meal: the traditional formulation, a formulation with a 25% reduction in sodium content, and a formulation with a 50% reduction in sodium content. Each participant will receive all three formulations in a randomized sequence, with 7 days washout periods between intervention periods.

Participants will consume three formulations of traditional Portuguese chouriça: a conventional formulation (traditional sodium content), a reformulated version with a 25% reduction in sodium content, and a reformulated version with a 50% reduction in sodium content. Sodium reduction is achieved through product reformulation, including partial replacement of sodium chloride with potassium chloride. Each formulation will be administered as a separate intervention during the crossover study, with washout periods between intervention periods.

Experimental: Butelo Intervention Group

Participants assigned to this group will consume three different formulations of tradition meat product 3 "butelo" in a day meal: the traditional formulation, a formulation with a 25% reduction in sodium content, and a formulation with a 50% reduction in sodium content. Each participant will receive all three formulations in a randomized sequence, with 7 days washout periods between intervention periods. The other meals of the day and of the previous day are standardized for all participants.

Participants will consume three formulations of traditional Portuguese butelo: a conventional formulation (traditional sodium content), a reformulated version with a 25% reduction in sodium content, and a reformulated version with a 50% reduction in sodium content. Sodium reduction is achieved through product reformulation, including partial replacement of sodium chloride with potassium chloride. Each formulation will be administered as a separate intervention during the crossover study, with washout periods between intervention periods.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24-hour urinary sodium excretion
Time Frame: 24 hours following consumption of each intervention product

Assessment of 24-hour urinary sodium excretion following consumption of traditional and sodium-reduced processed meat products.

24 hours following consumption of each intervention product
Changes in systolic and diastolic blood pressure following consumption of processed meat products with different sodium contents
Time Frame: Before and 2 hours after consumption of each intervention product.

Assessment of systolic and diastolic blood pressure before and after consumption of traditional and sodium-reduced processed meat products.

Before and 2 hours after consumption of each intervention product.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • InovC4Sa_sodium

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe